Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Lima VD, Monforte AD, Sterling TR, Miro J, Moreno S, Stephan C, Smith C, Tate J, Shepherd L, Saag M, Rieger A, Gillor D, Cavassini M, Montero M, Ingle SM, Reiss P, Costagliola D, Wit FWNM, Sterne J, de Wolf F, Geskus R, Antiretroviral Therapy Cohort Collaboration (ART-CC).

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2019. 80(3): 292-300. Nº de citas: 7

[doi:10.1097/QAI.0000000000001913]

Pérez-Molina JA, Martínez E, Blasco AJ, Arribas JR, Domingo P, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Mariño A, Miró JM, Moreno S, Negredo E, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, von Wichmann MA, Gatell JM.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2019. 37(3): 151-159. Nº de citas: 4

[doi:10.1016/j.eimc.2018.04.010]

Fernández-Ruiz M, Giménez E, Vinuesa V, Ruiz-Merlo T, Parra P, Amat P, Montejo M, Paez-Vega A, Cantisán S, Torre-Cisneros J, Fortún J, Andrés A, San Juan R, López-Medrano F, Navarro D, María Aguado J, Group for Study of Infection in Transplantation of the Spanish Society of Infect.

Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.

CLINICAL MICROBIOLOGY AND INFECTION 2019. 25(3): . Nº de citas: 16

[doi:10.1016/j.cmi.2018.05.010]

Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Canorea I, Guardiola JM, Crespo M, Quereda C, Sanz J, Carrero A, Hontañón V, Avellón A, Resino S.

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).

SCIENTIFIC REPORTS 2019. 9(1): 1143-1143. Nº de citas: 4

[doi:10.1038/s41598-018-37328-6]

Bouza, Emilio, Cobo, Javier, Almirante, Benito, Duenas, Carlos, Escudero, Rosa, Farinas, Carmen, Feher, Csaba, Pablo Horcajada, Juan, Merino, Esperanza, Merino, Paloma, Montejo, Miguel, Olmedo, Maria, Ramos-Martinez, Antonio, Rodriguez-Pardo, Dolors, Ruiz Mesa, Juan Diego, Salavert, Miguel, Sarria, Cristina, Tiago Silva, Jose, Grp Trabajo CLODIEXPAN.

Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile

REVISTA ESPANOLA DE QUIMIOTERAPIA 2019. 32(1): 50-59. Nº de citas: 1

Monge-Maillo B, Olmedo Samperio M, Pérez-Molina JA, Norman F, Mejía CR, Tojeiro SC, López-Vélez R.

Osseous cystic echinococcosis: A case series study at a referral unit in Spain.

PLOS NEGLECTED TROPICAL DISEASES 2019. 13(2): . Nº de citas: 10

[doi:10.1371/journal.pntd.0007006]

Heywood AE, López-Vélez R.

Reducing infectious disease inequities among migrants.

JOURNAL OF TRAVEL MEDICINE 2019. 26(2): . Nº de citas: 11

[doi:10.1093/jtm/tay131]

Polo Rodriguez, Rosa, Galindo Puerto, Maria Jose, Olalla, Julian, Gutierrez, Felix, Gomez Candela, Carmen, Abril, Vicente, Serrano, Sergio, Ramon Blanco, Jose, Villar, Noemi G. P., Miralles, Celia, Merchante, Angel, Estrada, Vicente, Duenas, Carlos, Sanz Sanz, Jesus, Palacios, Rosario, Lozano, Fernando, Marino, Ana, Asensi, Victor, Angel Von Wichmman, Miguel, Ortega, Enrique, Martinez Chamorro, Esteban, Panel Experts Metab Disorders Com, Natl Aids Plan PNS.

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2019. 37(1): 50-55. Nº de citas: 4

[doi:10.1016/j.eimc.2017.06.007]

Vizcarra P, Blanco JL, Montejano R, Negredo E, Espinosa N, Casado JL.

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy.

INFECTIOUS DISEASES 2019. 52(3): 1-5. Nº de citas: 2

[doi:10.1080/23744235.2019.1694696]

López-Medrano F, Silva JT, Fernández-Ruiz M, Vidal E, Origüen J, Calvo-Cano A, Luna-Huerta E, Merino E, Hernández D, Jironda-Gallegos C, Escudero R, Gioia F, Moreno A, Roca C, Cordero E, Janeiro D, Sánchez-Sobrino B, Montero MM, Redondo D, Candel FJ, Pérez-Flores I, Armiñanzas C, González Rico C, Del Carmen Fariñas M, Rodrigo E, Loeches B, López-Oliva MO, Montejo M, Lauzurica R, Horcajada JP, Pascual J, Andrés A, Aguado JM, REIPI, REDinREN, GESITRA-IC/SEIMC.

Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients - results of a Spanish multicenter cohort.

AMERICAN JOURNAL OF TRANSPLANTATION 2019. 20(2): 451-462. Nº de citas: 7

[doi:10.1111/ajt.15614]

Jarrin I, Suarez-Garcia I, Moreno C, Tasias M, Del Romero J, Palacios R, Peraire J, Gorgolas M, Moreno S.

Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.

ANTIVIRAL THERAPY 2019. 24(3): 167-175. Nº de citas: 5

[doi:10.3851/IMP3297]

Guerra Laso JM, Nebreda Mayoral T, Palacios Gutiérrez JJ, Samaniego González É, Rodríguez Martín B, Barrio Rodríguez L, Alonso Orcajo N, Magaz García E, Stinear T, Buultjens AH, Pérez Molina JA.

Buruli ulcers in a Spanish aid worker after a stay in Peru.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2019. 78: 99-102. Nº de citas: 1

[doi:10.1016/j.ijid.2018.10.012]

Wouthuyzen-Bakker M, Sebillotte M, Lomas J, Taylor A, Palomares EB, Murillo O, Parvizi J, Shohat N, Reinoso JC, Sánchez RE, Fernandez-Sampedro M, Senneville E, Huotari K, Allende JMB, Garcia-Cañete J, Lora-Tamayo J, Ferrari MC, Vaznaisiene D, Yusuf E, Aboltins C, Trebse R, Salles MJ, Benito N, Vila A, Toro MDD, Kramer TS, Petersdorf S, Diaz-Brito V, Tufan ZK, Sanchez M, Arvieux C, Soriano A, ESCMID Study Group for Implant-Associated Infections (ESGIAI).

Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention.

JOURNAL OF INFECTION 2019. 78(1): 40-47. Nº de citas: 38

[doi:10.1016/j.jinf.2018.07.014]

Serrano-Villar S, de Lagarde M, Vázquez-Castellanos J, Vallejo A, Bernadino JI, Madrid N, Matarranz M, Díaz-Santiago A, Gutiérrez C, Cabello A, Villar-García J, Blanco JR, Bisbal O, Sainz T, Moya A, Moreno S, Gosalbes MJ, Estrada V.

Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).

CLINICAL INFECTIOUS DISEASES 2019. 68(1): 120-130. Nº de citas: 25

[doi:10.1093/cid/ciy414]

Romero Lozano MA, Martín-Davila P, Reyes Valdivia AA, Bernal Bernal C.

Arterial infection caused by Listeria monocytogenes: Report of two cases. The efficacy of an early combined approach and oral suppressive treatment.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2019. 37(1): 60-61.

[doi:10.1016/j.eimc.2018.01.004]

Luis Casado J, Fontecha M, Monsalvo M, Vizcarra P.

Symtuza in clinical practice.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36 Suppl 2: 31-36.

[doi:10.1016/S0213-005X(18)30395-1]

Morte E, Tolmos M, Halperin A, Morosini MI, Cantón R, Hermida JM.

Early prosthetic endocarditis caused by Stenotrophomonas maltophilia.

Medecine et maladies infectieuses 2018. 48(8): 543-546. Nº de citas: 2

[doi:10.1016/j.medmal.2018.09.004]

Crespillo-Andújar C, Chamorro-Tojeiro S, Norman F, Monge-Maillo B, López-Velez R, Pérez-Molina JA.

Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.

CLINICAL MICROBIOLOGY AND INFECTION 2018. 24(12): . Nº de citas: 17

[doi:10.1016/j.cmi.2018.06.006]